This suggests that the DNA-PKcs inhibitor NU7026 and Rad51 inhibitor B02 sensitized cancer cells to the C ion irradiation via suppression of the NHEJR and HRR pathways, respectively. This evidence concerns the gene PRKDC and cancer.